menu
    • menu

    Company profile for Cytokinetics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and best-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. We are developing potential medicines to improve the healthspan of people with devastating cardiovascular and neuromuscular dis...
    Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and best-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. We are developing potential medicines to improve the healthspan of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function, like heart failure, hypertrophic cardiomyopathies (HCM), amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CytokineticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    280 East Grand Ave South San Francisco, CA 94115
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cytokinetics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cytokinetics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Cytokinetics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    US FDA Approves Cytokinetics' Heart Disease Drug
    US FDA Approves Cytokinetics' Heart Disease Drug

    19 Dec 2025

    // PRESS RELEASE

    https://ir.cytokinetics.com/press-releases/press-release-details/2025/Cytokinetics-Announces-FDA-Approval-of-MYQORZO-aficamten-for-the-Treatment-of-Adults-with-Symptomatic-Obstructive-Hypertrophic-Cardiomyopathy-to-Improve-Functional-Capacity-and-Symptoms/default.aspx

    PRESS RELEASE
    19 Dec 2025
    Share Share
    FDA Approves Cytokinetics' MYQORZO for Symptomatic Obstructive
    FDA Approves Cytokinetics' MYQORZO for Symptomatic Obstructive

    19 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/19/3208724/35409/en/Cytokinetics-Announces-FDA-Approval-of-MYQORZO-aficamten-for-the-Treatment-of-Adults-with-Symptomatic-Obstructive-Hypertrophic-Cardiomyopathy-to-Improve-Functional-Capacity-and-Sym.html

    GLOBENEWSWIRE
    19 Dec 2025
    Share Share
    Cytokinetics Issues Inducement Grants Per Nasdaq LR 5635(C)(4)
    Cytokinetics Issues Inducement Grants Per Nasdaq LR 5635(C)(4)

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/16/3206592/35409/en/Cytokinetics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-C-4.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share
    Cytokinetics Announces Positive CHMP Opinion of Myqorzo
    Cytokinetics Announces Positive CHMP Opinion of Myqorzo

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/12/3204645/35409/en/Cytokinetics-Announces-Positive-CHMP-Opinion-of-MYQORZO-Aficamten-for-the-Treatment-of-Obstructive-Hypertrophic-Cardiomyopathy.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share
    Cytokinetics Issues Inducement Grants Per Nasdaq LR 5635(C)(4)
    Cytokinetics Issues Inducement Grants Per Nasdaq LR 5635(C)(4)

    18 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/18/3190469/35409/en/Cytokinetics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-C-4.html

    GLOBENEWSWIRE
    18 Nov 2025
    Share Share
    Cytokinetics Doesn'T Want Big Pharma Help To Overtake Camzyos
    Cytokinetics Doesn'T Want Big Pharma Help To Overtake Camzyos

    18 Nov 2025

    // FIERCE PHARMA

    https://www.fiercebiotech.com/biotech/were-built-it-why-cytokinetics-doesnt-want-big-pharma-support-supersede-camzyos

    FIERCE PHARMA
    18 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search